Medication after stomach cancer removal for ulcer healing
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study tests whether adding sucralfate (a stomach-lining protectant) to the standard acid-reducer esomeprazole helps heal ulcers that form after a procedure called ESD for early stomach cancer. It helps find which combination works better for recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a diagnosis of early stomach cancer or pre-cancerous changes and will have a procedure called ESD to remove the abnormal tissue.
- The targeted area can be in the main part of your stomach (body), lower part (antrum), or the curve between them. If it's near the top, you may still join but will be looked at separately.
- The tissue removed during ESD must be successfully taken out in one piece, and any visible bleeding vessels must be sealed.
- The ulcer left after ESD must be at least 2 cm wide (about the size of a grape).
- You are generally in good health (able to do light activities) and can follow up with clinic visits and follow-up endoscopies.
- You agree to join voluntarily and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at early stomach cancer treated with ESD, a procedure to remove the tumor through the stomach lining, and how the depth of the scar relates to healing. It may help doctors predict better outcomes and improve the procedure for suitable patients.
This study tests a new medicine to help heal stomach ulcers. It may be an option if you have a stomach ulcer that is not too large and is at a certain stage of healing.
This trial compares two medicines that reduce stomach acid to help heal ulcers that form after a procedure called ESD, which removes abnormal stomach tissue. The goal is to see if one medicine works better and has fewer side effects.
This trial tests a technique called full-time RDI during ESD (a minimally invasive procedure to remove early stomach cancer). The goal is to see if it can lower the chance of serious side effects and shorten the procedure time. If you are scheduled for this surgery and meet the health requirements, you may be able to join.
This trial tests a medicine called esomeprazole, given through an IV, to see if it safely prevents stomach bleeding in patients who are in the ICU after surgery. If you qualify, you might get this medicine to help protect your stomach while you recover.
This trial tests a special stitching tool to close holes in the stomach after removing abnormal growths. It may help patients heal better after a routine procedure to remove suspicious tissue.
Hear when a new Early Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.